News aap Implantate AG

Equities

AAQ1

DE000A3H2101

Market Closed - Xetra Other stock markets 11:36:00 2024-05-07 am EDT			5-day change	1st Jan Change
1.31 ^EUR	-5.76%		+12.93%	+57.83%

2021	Aap Implantate AG Announces Sales Results for the Second Quarter and Half Year Ended 30 June 2021	CI
2021	Aap Implantate Ag Reports Earnings Results for the Full Year Ended December 31, 2020	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aap Implantate AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	Apr. 22	EQ
Aap closes Q1 2024 with sales growth of 5.6% and positive developments at all operating levels and makes a strong start to Q2 2024	Apr. 22	EQ
NVR: aap Implantate AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	Apr. 19	EQ
Aap successfully places a 10% capital increase from authorized capital at EUR 1.10 with exclusion of subscription rights	Apr. 19	EQ
Aap Implantate AG: aap postpones publication of the consolidated financial statements 2023 due to staff shortages	Apr. 17	EQ
Aap 100% approval of the proposed resolution to amend the terms and conditions of the mandatory convertible bond 2023/2028	Apr. 03	EQ
Aap Implantate AG: Capital increase from authorized capital with exclusion of subscription rights	Mar. 18	EQ
Aap proposes to the bondholders of the mandatory convertible bond 2023/2028 an amendment to the bond terms and conditions to enable the bondholders to exercise their conversion rights earlier	Mar. 05	EQ
After a mixed 2023 financial year, aap makes a strong start to the 2024 financial year	Feb. 15	EQ
Aap Implantate : with positive EBITDA in Q2 and H1/2021 for first time since focusing on trauma and significant sales growth of +74% (Q2) and +37% (H1)	21-08-13	PU
Aap Implantate : with positive EBITDA in Q2 and H1/2021 for first time since focusing on trauma and significant sales growth of +74% (Q2) and +37% (H1)	21-08-13	EQ
Aap Implantate AG Announces Sales Results for the Second Quarter and Half Year Ended 30 June 2021	21-07-27	CI
Q1/21: Successful start to the year with sales growth (+9%) and significant earnings improvement (+91%) despite still burdening COVID-19 pandemic - restructuring successes clearly visible	21-05-28	EQ
Aap Implantate Ag Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-30	CI
2020 financial statements: visible results under restructuring with significantly improved Recurring EBITDA (+28%) in challenging times of COVID-19 pandemic	21-04-30	EQ
Aap Implantate AG Provides Earnings Guidance for the Year 2021	21-04-30	CI
Q1/2021: Solid start to year with 9% sales growth despite still burdening COVID 19 pandemic; more than 500 surgeries in US mark new high; Q2 order book well filled	21-04-26	EQ
Aap Implantate AG Announces Sales Results for the First Quarter of 2021	21-04-26	CI
Aap Implantate AG Provides Sales Guidance for the Second Quarter of 2021	21-04-26	CI
Aap Implantate : Publication of annual financial statements 2020 on 30 April 2021	21-03-10	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News aap Implantate AG

Equities

AAQ1

DE000A3H2101

Summary

Filters